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Abstract
Introduction: Patients	with	Cystic	Fibrosis	(CF)	have	increasing	rates	of	hospitalization.	We	analyzed	the	burden	and	predictors	
of	thirty-day	readmission	among	patients	with	CF	in	the	U.S.	
Material and methods: Nationwide	Readmission	Database	(NRD)	2013	was	used	to	identify	adults	with	CF	who	were	hospi-
talized.	These	individuals	were	followed	to	determine	the	prevalence	of	readmission	within	thirty	days	of	index	discharge.	Cox	
proportional	hazard	regression	was	used	to	identify	independent	predictors	of	readmission.	
Results: There	were	14,616	index	admissions	of	adults	with	CF	in	2013.	Of	these,	2,606	(17.8%)	patients	were	readmitted	within	
30	days	of	discharge.	Female	sex	and	chronic	anemia	were	independent	predictors	of	readmission.	The	most	common	causes	of	
readmission	were	pulmonary	exacerbation	(31%),	lung	transplant	complications	(5.2%),	and	septicemia	(3.4%).
Conclusion: Readmissions	are	frequent	among	adults	with	CF	and	contribute	to	significant	healthcare	burden	and	cost	among	
this population. 
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Introduction
Patients with cystic fibrosis (CF) have high ra-
tes of hospitalization. In the United States (U.S.), 
the annual rate of hospitalizations per 1,000 CF 
patients has increased from 994 to 1072 between 
2003 and 2013 [1]. Individuals with CF are pro-
ne to frequent readmissions due to pulmonary 
exacerbation, non-pulmonary comorbidities in 
CF, or complications related to therapy. These 
readmissions can impact quality of life of CF pa-
tients as well as lead to frequent health exposure 
and associated complications. There is lack of 
data on the burden of readmissions among this 
population. We aim to determine the prevalence 
of thirty-day readmissions among adults with CF 
in the U.S and its predictors. 
Material and methods
We used Nationwide Readmission database 
(NRD) 2013 which is an all-payer nationally 
representative database developed by Agency 
for Healthcare Research and Quality (AHRQ) for 
Healthcare Cost and Utilization Project (HCUP) 
[2]. We identified our index admission as the first 
hospitalization of adult (age ≥ 18 years) with CF 
(ICD-9-CM codes 277.00 to 277.09). We identified 
index admissions and thirty day readmissions 
based on the criteria of Centers for Medicare and 
Medicaid Services (CMS) [3]. Any hospitalization 
within 30 days of an index discharge was consi-
dered a readmission, and any admission beyond 
30 days of index discharge was a separate index 
admission. Patients with age < 18 years and those 
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missing information on key demographics (age and 
gender) were excluded. We also excluded patients 
who died during index admission as they were 
not at risk of readmission and patients with index 
discharges in December due to lack of sufficient 
time to capture their thirty-day readmissions [4]. 
Sampling weights provided were used to produce 
national level estimates. The primary objective was 
to determine the prevalence of thirty-day readmis-
sions among hospitalized adults with CF. Secon-
dary objectives were to determine the predictors 
of readmissions and the common indications for 
readmissions. We also performed cost and length of 
stay comparison between index admissions and re-
admissions. To identify the independent predictors 
of readmission, Cox proportional hazards regression 
model was used. The time to the first readmission 
from index discharge was defined as the time to 
event. Index hospitalizations without subsequent 
readmissions within thirty days of discharge were 
right censored. The covariates included in the mo-
del were patient demographics, Elixhauser comor-
bidities, in-hospital complications, lung transplant 
status, primary payer, and economic status of the 
patient (surrogated by median household income 
quartile of patient’s ZIP code). 
Results
Between January and November 2013, there 
were 14,616 index hospitalizations of adults 
with CF. Their mean age was 30.4 years (SD 11.6) 
and 53% were females. The demographics and 
co-morbidities are shown in detail in Table 1. 
Based on CF registry annual report, there were 
approximately 13,967 adults with CF in the U.S. 
in 2013 [5]. Our analysis estimates that of these, 
8,228 (59%) individuals were at least hospitalized 
once during 2013.
Among the 14,616 index admissions, 2,606 
(17.8%) patients were readmitted within 30 days 
of index discharge. Compared to patients witho-
ut readmissions, those who got readmitted had 
higher proportion of females, had higher preva-
lence of chronic liver disease (8.3% vs 5.6%, p < 
0.001), chronic anemia, diabetes, lung transplant 
recipients, and acute kidney injury (AKI) during 
index admission (Table 1). However, after mul-
tivariate adjustment (listed in methods) on cox 
proportional hazard regression, the independent 
predictors for any cause thirty-day readmissions 
were female sex (Hazard Ratio, HR = 1.19, p 
= 0.041) and chronic anemia (HR = 1.52, p < 
0.001) (Table 2). Age, lung transplant status, AKI, 
diabetes, or liver disease did not have any effect 
on readmission risk. 
The median time to the first readmission after 
index discharge was 15 days. Readmissions had a 
higher mean cost than index admissions ($26,274 
vs $20062, p < 0.001) despite similar length of 
stay (median = 7 days in both). The most common 
reasons for readmissions were pulmonary exa-
cerbation (31%), lung transplant complications 
(5.2%), and septicemia (3.4%). 
Discussion
This is the first study to report the burden and 
predictors of readmissions among adults with CF 
in a nationally representative sample. Our data 
show that about 18% of adults with CF who are 
hospitalized get readmitted within thirty days. 
This high readmission rate is similar to that of 
other respiratory conditions with a high burden 
of readmissions like COPD and pneumonia [4, 6]. 
The annual number of hospitalizations of patients 
with CF as well hospitalizations per thousand 
CF patients has increased over the past decade 
Table 1.  Demographic characteristics and comorbidities of index admissions (with and without readmissions). All cells in 
the table represent percentage distribution unless otherwise specified in first column. P-value in the last column 
represents the significance of difference of characteristics between index admission without readmission group 
and index admission with at least 1 readmission group
Covariate Hazard ratio (95% confidence interval) p-value
Age 0.99	(0.98–1.00) 0.087
Female	(male-referent) 1.19	(1.01–1.41) 0.041
Lung	transplant 1.16	(0.82–1.65) 0.402
Acute	kidney	injury 1.21	(0.96–1.54) 0.115
Chronic anemia 1.52	(1.25–1.85) < 0.001
Diabetes 1.22	(0.99–1.48) 0.054
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[1]. With the increasing age of the CF population 
and longer survival, the readmissions for adults 
with CF are expected to increase over time. This 
might lead to even further increase in the annual 
rate of hospitalizations among this population. 
Recognizing patients at high risk (such as those 
with chronic anemia) and targeted interventions 
is necessary to reduce readmissions among these 
patients. 
The role of routine follow-up shortly after 
discharge in reduction of readmissions (similar to 
patients with congestive heart failure) in CF has 
not been examined [7]. Theoretically, such a fol-
low up would be beneficial to address any acute 
symptoms, compliance with various therapies, as-
sess nutritional and psychosocial status following 
a hospitalization among CF patients. Whether this 
would lead to a decrease in readmissions needs 
to be studied. Our study also highlights the key 
impact of readmissions on healthcare costs. As 
the readmissions have a higher mean cost com-
pared to index hospitalizations, they contribute 
to a significant healthcare burden and cost among 
adults with CF. 
The results of our study should be interpreted 
in the light of several limitations. First, as NRD is 
an administrative database, the selection of study 
population might be subjected to coding errors 
and misclassification. Secondly, lab values and 
data on severity of CF such as results of pulmo-
nary function tests were not available. Therefore, 
there remains a risk of residual confounding 
despite adjusting for multiple variables in the 
regression model. 
Conclusion
In conclusion, in a nationally representative sam-
ple, about 18% of hospitalized adults with CF were 
readmitted within thirty days. Females and patients 
with chronic anemia are at higher risk of readmis-
sion. Readmissions had a higher cost of healthcare 
compared to index admissions among CF patients. 
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Table 2.  Results of the Cox proportional hazard regression demonstrating the hazard ratio (HR) and 95% confidence in-
tervals (CI). The HR represents the risk of thirty-day readmission
  All index admissions
(n = 14,616)
Index admission without 
readmission
(n = 12,010)
Index admission with 
readmission
(n = 2,606)
p-value
Mean	age,	years	(SD) 30.4	(11.6) 30.5	(11.6) 30.1	(11.3) 0.152
Gender
    Male 46.6 47.6 42.1 < 0.001
    Female 53.4 52.4 57.9
Lung	transplant	(previous	or	current) 5.5 5.2 7.2 < 0.001
Acute	kidney	injury 6.4 5.4 11.2 < 0.001
Chronic anemia 14.7 12.9 23.2 < 0.001
Diabetes 40.4 38.8 47.7 < 0.001
Median	length	of	stay	(IQR),	days 7	(8) 7	(8) 8	(9) < 0.001
